Attached files

file filename
EX-31.2 - CERTIFICATION - BioNexus Gene Lab Corpbion_ex312.htm
EX-31.1 - CERTIFICATION - BioNexus Gene Lab Corpbion_ex311.htm
10-Q/A - FORM 10-Q/A - BioNexus Gene Lab Corpbion_10qa.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of the registrant certify, to the best of their knowledge, that the registrant's Amendment No. 1 to Quarterly Report on Form 10-Q for the period ended September 30, 2020 (the "Form 10-Q") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q, fairly presents, in all material respects, the financial condition and results of operations of the registrant.

  

Bionexus Gene Lab Corporation

 

Dated: November 5, 2020

 

/s/ Chan Chong Wong                                                                     

Chan Chong Wong

Chief Executive Officer and Director

(Principal Executive Officer)

 

/s/ Wei Li Leong                                                                                  

Wei Li Leong

Chief Financial Officer